[
  {
    "ts": null,
    "headline": "BioTechne (TECH) Fell Over the Industry’s Uncertain Funding Environment",
    "summary": "Mairs & Power, an investment advisor, released the “Mairs & Power Balanced Fund” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The quarter started with tariff uncertainty, conflicts in the Middle East, rising national debt, and the worst start to a year for the dollar; however, it bounced back […]",
    "url": "https://finnhub.io/api/news?id=d32e12978ae1e52258d14dd00a5ecccc287e95bac0484dc336c4faec72afa097",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758713332,
      "headline": "BioTechne (TECH) Fell Over the Industry’s Uncertain Funding Environment",
      "id": 136862267,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Mairs & Power, an investment advisor, released the “Mairs & Power Balanced Fund” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The quarter started with tariff uncertainty, conflicts in the Middle East, rising national debt, and the worst start to a year for the dollar; however, it bounced back […]",
      "url": "https://finnhub.io/api/news?id=d32e12978ae1e52258d14dd00a5ecccc287e95bac0484dc336c4faec72afa097"
    }
  },
  {
    "ts": null,
    "headline": "Is Bio-Techne Stock Underperforming the Dow?",
    "summary": "Bio-Techne has significantly underperformed the Dow over the past year, but analysts are cautiously optimistic about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=d344334ac2b32bdf14f68e047cedfbeaff5b81af3218f6d4168162f1bc153d8d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758712531,
      "headline": "Is Bio-Techne Stock Underperforming the Dow?",
      "id": 136862269,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Bio-Techne has significantly underperformed the Dow over the past year, but analysts are cautiously optimistic about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=d344334ac2b32bdf14f68e047cedfbeaff5b81af3218f6d4168162f1bc153d8d"
    }
  },
  {
    "ts": null,
    "headline": "Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report",
    "summary": "Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today released its 2025 Corporate Sustainability Report, underscoring the company's commitment to advancing human health while protecting the planet.",
    "url": "https://finnhub.io/api/news?id=26e038b125b69769649366d2325707885370b3cf8f08e012910446451e4f8a1e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758711540,
      "headline": "Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report",
      "id": 136862270,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today released its 2025 Corporate Sustainability Report, underscoring the company's commitment to advancing human health while protecting the planet.",
      "url": "https://finnhub.io/api/news?id=26e038b125b69769649366d2325707885370b3cf8f08e012910446451e4f8a1e"
    }
  }
]